Harald Reinhart - Sep 7, 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld
Stock symbol
ZLAB
Transactions as of
Sep 7, 2021
Transactions value $
-$1,479,259
Form type
4
Date filed
9/8/2021, 09:02 PM
Previous filing
Aug 25, 2021
Next filing
Sep 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $30K +10K $3.00* 10K Sep 7, 2021 Direct F1
transaction ZLAB Ordinary Shares Sale -$14.3K -100 -1% $143.00* 9.9K Sep 7, 2021 Direct F1
transaction ZLAB Ordinary Shares Sale -$29.4K -200 -2.02% $146.98* 9.7K Sep 7, 2021 Direct F1, F2
transaction ZLAB Ordinary Shares Sale -$44.6K -300 -3.09% $148.69* 9.4K Sep 7, 2021 Direct F1, F3
transaction ZLAB Ordinary Shares Sale -$301K -2K -21.28% $150.41* 7.4K Sep 7, 2021 Direct F1, F4
transaction ZLAB Ordinary Shares Sale -$998K -6.6K -89.19% $151.28* 800 Sep 7, 2021 Direct F1, F5
transaction ZLAB Ordinary Shares Sale -$122K -800 -100% $152.11* 0 Sep 7, 2021 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -10K -30% $0.00 23.3K Sep 7, 2021 Ordinary Shares 10K $3.00 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 Reflects a weighted average sale price of $146.98 per share, at prices ranging from $146.66 to $147.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Reflects a weighted average sale price of $148.69 per share, at prices ranging from $148.23 to $148.92 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 Reflects a weighted average sale price of $150.41 per share, at prices ranging from $149.80 to $150.78 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 Reflects a weighted average sale price of $151.28 per share, at prices ranging from $150.84 to $151.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 Reflects a weighted average sale price of $152.11 per share, at prices ranging from $151.85 to $152.50 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7 The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant.